Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) P/B ratio
As of 25 September 2026, Henry Schein, Inc. (HSIC) trades at a P/B ratio of 2.6×. Over the past ten years it has ranged from 1.8× (March 2020) to 4.1× (June 2017); the current reading is higher than 41% of that period. That is in line with the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 2.3× | 7.59% |
| FY2024 | 2.2× | (5.41%) |
| FY2023 | 2.3× | (13.00%) |
| FY2022 | 2.6× | (1.06%) |
| FY2021 | 2.7× | 11.79% |
| FY2020 | 2.4× | (11.98%) |
| FY2019 | 2.7× | 2.36% |
| FY2018 | 2.7× | (14.69%) |
| FY2017 | 3.1× | (11.84%) |
| FY2016 | 3.5× | (0.89%) |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2.5× | 14.85% |
| Mar 2026 | 2.2× | (7.70%) |
| Dec 2025 | 2.3× | 18.10% |
| Sep 2025 | 2.0× | (8.99%) |
| 42 more quarters | Free account |
Against its own ten years
Low 1.8×
High 4.1×
Ten-year median
2.7×
Current reading's percentile
41
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| MCK McKesson Corporation compare | n/m |
| ACH Accendra Health, Inc. compare | n/m |
| CAH Cardinal Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | 0.1× |
| COSM Cosmos Health Inc. compare | 1.0× |
| HSIC Henry Schein, Inc. | 2.6× |
| COR Cencora, Inc. compare | 18.3× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement